glp 1 is insulin Schematic of action of GLP-1 on secretion GLP-1 Agonists: Increasing Effective Insulin

Do they deepen our bias against fat and make life more miserable draining patients not just of money but also dignity and joy

Clinical trials demonstrate tirzepatide produces greater weight loss than semaglutide alone, making it an evidence-based next step for plateau patients

Shima Hadidchi for Weight Loss and Oral Semaglutide Treatment

GLP-1 (glucagon-like peptide-1) receptor agonists are injectable medications that: Slow digestion to reduce appetite Stimulate insulin production to lower blood sugar Promote weight loss (up to 15% of body weight in some cases) Common brands include: Ozempic (semaglutide) for type 2 diabetes Wegovy (semaglutide) for obesity Mounjaro (tirzepatide) for diabetes and weight loss According to the American Diabetes Association, over 8 million Americans now use GLP-1 drugs-and their foot health impacts are significant